Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CASP2 | P42575 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18649603 | 0.91 | KDM4E (0.54) | KMT2AMEN1ALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL18649601 | 0.91 | KMT2A (0.41) | KMT2AMEN1ALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL19069757 | 0.89 | CASP2 (0.50) | KMT2AMEN1CASP2NAAAFAAH | |
| SCHEMBL22014139 | 0.86 | MEN1 (0.38) | KMT2AMEN1ALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL22931711 | 0.85 | MEN1 (0.45) | KMT2AMEN1ALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL12360826 | 0.85 | CASP2 (0.62) | KMT2AMEN1CASP2NAAAFAAH | |
| SCHEMBL24330217 | 0.83 | GAA (0.39) | KMT2AMEN1ALDH1A1SMN1; SMN2PKM | |
| SCHEMBL21472789 | 0.83 | KMT2A (0.39) | KMT2AMEN1ALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL20829941 | 0.83 | PAOX (0.57) | KMT2AMEN1ALDH1A1SMN1; SMN2CASP2 | |
| SCHEMBL17010827 | 0.83 | PAOX (0.47) | KMT2AMEN1SMN1; SMN2CASP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120164039-A1 | PALLADIUM ION ADSORBENT AND METHODS FOR SEPARATING AND RECOVERING PALLADIUM USING IT | TOSOH CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
| WO-2011021696-A1 | PALLADIUM ION ADSORBENT AND METHOD FOR SEPARATING AND RECOVERING PALLADIUM USING SAME | 東ソー株式会社 (JP) | 2011-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164039-A1 | PALLADIUM ION ADSORBENT AND METHODS FOR SEPARATING AND RECOVERING PALLADIUM USING IT | PDCD10, PARK7, CCR10 | KMT2A 643/4885MEN1 1969/4885ALDH1A1 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.